De novo relapsing-remitting multiple sclerosis following autologous stem cell transplantation.

De novo relapsing-remitting multiple sclerosis following autologous stem cell transplantation.

Bibliographic Details
Main Authors:	Armstrong, R, Elston, J, Hatton, C, Ebers, G
Format:	Journal article
Language:	English
Published:	2010

Similar Items

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
by: Antonio Bertolotto, et al.
Published: (2020-06-01)

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
by: Aina Vaivade, et al.
Published: (2023-07-01)

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
by: Peter J. Darlington, et al.
Published: (2018-05-01)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis - Authors' reply
by: Filippini, G, et al.
Published: (2003)

Interferons in relapsing remitting multiple sclerosis: a systematic review.
by: Filippini, G, et al.
Published: (2003)

Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines
by: Paty, D, et al.
Published: (1999)

Interferons in relapsing remitting multiple sclerosis.
by: Goodin, D
Published: (2003)

Natalizumab for relapsing-remitting multiple sclerosis
by: A. Horga, et al.
Published: (2011-01-01)

Thalamic neurodegeneration in relapsing: Remitting multiple sclerosis
by: Cifelli, A, et al.
Published: (2003)

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis.
by: Wylezinska, M, et al.
Published: (2003)

Postural Control in Relapsing-Remitting Multiple Sclerosis
by: Flavia Salvaterra Cusin, et al.
Published: (2022-10-01)

Advances in the treatment of relapsing - Remitting multiple sclerosis
by: Radu Tanasescu, et al.
Published: (2014-04-01)

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01)

Cognitive impairment in relapsing remitting Multiple Sclerosis
by: Saška Roškar
Published: (2003-06-01)

Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
by: V. Casado, et al.
Published: (2021-07-01)

A case of multiple sclerosis—like relapsing remitting encephalomyelitis following allogeneic hematopoietic stem cell transplantation and a review of the published literature
by: Das, J, et al.
Published: (2020)

A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
by: Joyutpal Das, et al.
Published: (2020-05-01)

Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
by: Wendy Gilmore, et al.
Published: (2020-06-01)

Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis
by: Nicole Kashani, et al.
Published: (2021-10-01)

Oxidative stress in relapsing-remitting multiple sclerosis patients
by: Samaneh Sabouri, et al.
Published: (2023-09-01)

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2010-08-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
by: Halil Önder
Published: (2019-06-01)

Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
by: Burgal María, et al.
Published: (2010-04-01)

Serum prolactin in patients with relapsing remitting multiple sclerosis
by: Hoda A. Alwakil, et al.
Published: (2020-07-01)

Mild cognitive impairment in relapsing-remitting multiple sclerosis
by: Dimakopoulou Aikaterini, et al.
Published: (2008-04-01)

Cognitive profile of patients with relapsing remitting multiple sclerosis
by: VIVIAN M. ANDRADE, et al.
Published: (1999-09-01)

Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial
by: Gavin Giovannoni, et al.
Published: (2024-02-01)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
by: Jan Lycke, et al.
Published: (2020-06-01)

Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
by: Gatzonis Stylianos, et al.
Published: (2009-08-01)

Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis
by: Forooz Peiravian, et al.
Published: (2016-09-01)

Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS).
by: Lesage, E, et al.
Published: (2010)

Prooxidant-antioxidant balance in relapsing-remitting multiple sclerosis patients
by: Samaneh Sabouri, et al.
Published: (2023-07-01)

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
by: Sainz de la Maza S, et al.
Published: (2023-06-01)

The condition of the cardiovascular system in patients with relapsing-remitting multiple sclerosis
by: O. A. Traktirskaya, et al.
Published: (2019-03-01)

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis
by: Quentin Howlett-Prieto, et al.
Published: (2023-01-01)

Dimethyl fumarate in the treatment of relapsing–remitting multiple sclerosis: an overview
by: Roberto Bomprezzi
Published: (2015-01-01)

Systematic review of prediction models in relapsing remitting multiple sclerosis.
by: Fraser S Brown, et al.
Published: (2020-01-01)

Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
by: Romme Christensen Jeppe, et al.
Published: (2012-09-01)

Long-term daclizumab therapy in relapsing-remitting multiple sclerosis
by: Monica A. Rojas, et al.
Published: (2009-09-01)